CKPT - Checkpoint Therapeutics, Inc.

QQQ $ 612.11 $ 7.61 (1.26 %)

DIA $ 467.12 $ 5.24 (1.13 %)

SPY $ 671.75 $ 6.91 (1.04 %)

TLT $ 91.68 $ 0.35 (0.38 %)

GLD $ 401.36 $ 14.16 (3.64 %)

Previous Close

$ 4.26

Open

Bid

-- x --

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 1.80 - $ 4.50

Volume

8,666,849

Average Volume

Market Cap

370.71M

Beta (5Y Monthly)

$ 0.93

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-13-2025	03-31-2025	10-Q
2	03-28-2025	12-31-2024	10-K
3	11-12-2024	09-30-2024	10-Q
4	08-12-2024	06-30-2024	10-Q
5	05-10-2024	03-31-2024	10-Q
6	03-22-2024	12-31-2023	10-K
7	11-13-2023	09-30-2023	10-Q
8	08-14-2023	06-30-2023	10-Q
9	05-15-2023	03-31-2023	10-Q
10	03-31-2023	12-31-2022	10-K
11	11-10-2022	09-30-2022	10-Q
12	08-12-2022	06-30-2022	10-Q
13	05-12-2022	03-31-2022	10-Q
14	03-28-2022	12-31-2021	10-K
15	11-04-2021	09-30-2021	10-Q
16	08-06-2021	06-30-2021	10-Q
17	05-07-2021	03-31-2021	10-Q
18	03-12-2021	12-31-2020	10-K
19	11-06-2020	09-30-2020	10-Q
20	08-06-2020	06-30-2020	10-Q
21	05-07-2020	03-31-2020	10-Q
22	03-11-2020	12-31-2019	10-K
23	11-12-2019	09-30-2019	10-Q
24	08-08-2019	06-30-2019	10-Q
25	05-10-2019	03-31-2019	10-Q
26	03-18-2019	12-31-2018	10-K
27	11-02-2018	09-30-2018	10-Q
28	08-07-2018	06-30-2018	10-Q
29	05-10-2018	03-31-2018	10-Q
30	03-16-2018	12-31-2017	10-K
31	11-03-2017	09-30-2017	10-Q
32	08-09-2017	06-30-2017	10-Q
33	05-10-2017	03-31-2017	10-Q
34	03-17-2017	12-31-2016	10-K
35	11-14-2016	09-30-2016	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Checkpoint Therapeutics Q1 EPS $(0.19) Mis...
05/13/2025 20:42:02

Checkpoint Therapeutics (NASDAQ:CKPT) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimat...

D. Boral Capital Maintains Buy on Checkpoi...
03/31/2025 11:33:59

D. Boral Capital analyst Jason Kolbert maintains Checkpoint Therapeutics (NASDAQ:CKPT) with a Buy and maintains $4.8 price t...

this-lennar-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-tuesday

This Lennar Analyst Is No Longer Bullish; ...
03/11/2025 13:14:54

HC Wainwright & Co. Downgrades Checkpoint ...
03/11/2025 10:39:26

HC Wainwright & Co. analyst Joseph Pantginis downgrades Checkpoint Therapeutics (NASDAQ:CKPT) from Buy to Neutral and an...

Lake Street Downgrades Checkpoint Therapeu...
03/10/2025 19:33:35

Lake Street analyst Thomas Flaten downgrades Checkpoint Therapeutics (NASDAQ:CKPT) from Buy to Hold and lowers the price tar...

dow-tumbles-over-600-points-mineralys-therapeutics-shares-spike-higher

Dow Tumbles Over 600 Points; Mineralys The...
03/10/2025 17:09:11

india-based-sun-pharma-to-buy-us-cancer-firm-checkpoint-therapeutics-details

India-Based Sun Pharma To Buy US Cancer Fi...
03/10/2025 15:08:51

Sun Pharma to acquire Checkpoint Therapeutics for $4.10 per share, with potential CVR. FDA approves Unloxcyt, the first PD-L1 b...

D. Boral Capital Maintains Buy on Checkpoi...
03/10/2025 14:51:28

D. Boral Capital analyst Jason Kolbert maintains Checkpoint Therapeutics (NASDAQ:CKPT) with a Buy and lowers the price targe...

nasdaq-dips-over-3-checkpoint-therapeutics-shares-jump

Nasdaq Dips Over 3%; Checkpoint Therapeuti...
03/10/2025 14:50:01

us-stocks-likely-to-open-lower-after-trump-hints-at-looming-recession-expert-says-cant-rule-out-a-bear-market-as-indices-inch-towards-correction-territory

US Stocks Likely To Open Lower After Trump...
03/10/2025 11:29:50

U.S. stock futures declined on Monday after a small bout of relief on Friday as indices neared the correction zone.

why-checkpoint-therapeutics-shares-are-trading-higher-by-around-66-here-are-20-stocks-moving-premarket

Why Checkpoint Therapeutics Shares Are Tra...
03/10/2025 10:44:47

Reported Earlier, Sun Pharma To Acquire Ch...
03/10/2025 06:28:50

Will add UNLOXCYT™ (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced ...

this-pge-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday

This PG&E Analyst Begins Coverage On A Bul...
01/13/2025 14:28:12

D. Boral Capital Initiates Coverage On Che...
01/13/2025 12:31:38

D. Boral Capital analyst Jason Kolbert initiates coverage on Checkpoint Therapeutics (NASDAQ:CKPT) with a Buy rating and ann...

Lake Street Maintains Buy on Checkpoint Th...
12/16/2024 16:30:05

Lake Street analyst Thomas Flaten maintains Checkpoint Therapeutics (NASDAQ:CKPT) with a Buy and raises the price target fro...

Checkpoint Therapeutics shares are trading...
12/16/2024 15:11:41

fda-approves-checkpoint-therapeutics-skin-cancer-drug-one-year-after-rejection

FDA Approves Checkpoint Therapeutics' Skin...
12/16/2024 14:22:01

Checkpoint Therapeutics' Unloxcyt wins FDA approval for advanced cSCC, marking the company's entry into the U.S. market...

HC Wainwright & Co. Reiterates Buy on Chec...
12/16/2024 12:27:19

HC Wainwright & Co. analyst Joseph Pantginis reiterates Checkpoint Therapeutics (NASDAQ:CKPT) with a Buy and maintains $...

us-stocks-to-open-higher-ahead-of-feds-decision-this-week-analyst-says-santa-comes-later-in-december

US Stocks To Open Higher Ahead Of Fed's De...
12/16/2024 11:24:52

U.S. stock futures were trading higher after the Nasdaq 100 extended its relentless climb last week, nearing the 22,000-point m...

Reported Friday, FDA Approves Checkpoint T...
12/16/2024 07:35:33

"Today's FDA approval of UNLOXCYT – the first marketing approval for our company – is a significant milestone both for ...